ARTICLE | Clinical News
Caelyx pegylated liposomal doxorubicin regulatory update
February 5, 2001 8:00 AM UTC
AZA received approval in Canada for Caelyx to treat advanced ovarian cancer in women who have failed first-line platinum-based therapy. Caelyx, which also is approved in Canada to treat AIDS-related K...